Furthermore, 11 tumors, namely ACC, BLCA, BRCA, ESCA, GBM, HNSC, KIRP, LUAD, LUSC, PAAD, and SKCM, exhibited a positive correlation between CDKN2A CNA and the expression of CCR6 (Figure 10). This evidence concerns the gene CDKN2A and pancreatic adenocarcinoma.